BioFab3D@ACMD is a hospital-based robotics and biomedical engineering centre, bringing together researchers, clinicians, engineers and industry partners to work alongside each other with a vision to build biological structures.
The centre will embed research into the clinical setting and clinical needs into the research environment to increase and accelerate the rates of clinical breakthroughs such as the BioPen, to replace and ultimately allow regrowth of bone.
Bringing together the group's scientists, clinicians and industry partners as a single cohesive group at the point of care will enable immediacy in problem solving, give greater context to the research programme and allow solutions brought by experts in the field to be finely honed by patients' real world problems.
Through developing relationships with Australian and international companies, the facility will enable an appreciation of international market trends (historically been hard to obtain in Australia), and improve capabilities to engage with international markets and global supply chains.
Outcomes: During 2021 the BioFab consortium have collaborated on 14 successful grant application, totalling over $3 million dollars. Going forward, the BioFab model will serve as a template for the Aikenhead Centre for Medical Discovery (ACMD) when it opens in 2024. ACMD will expand the model further and on a larger scale with 9 partners co-locating in one building. Based on the success of the BioFab model, it is anticipated that more translational projects will eventuate and produce personalised treatment in the area of osteoarthritis, epilepsy, muscle and nerve regeneration.
|Consortium lead||St Vincent's Hospital|
|Consortium members|| |
University of Melbourne, University of Wollongong, Swinburne University of Technology, RMIT University, Stryker Australia Pty Ltd
|Project Duration||March 2017 - March 2018|
|Contact||Andrew Crettenden, St Vincent's Hospital - Andrew.Crettenden@svha.org.au|
For more information, visit BioFab3D@ACMD.
Listen to our podcast episode as BioFab3D's Centre Manager Cathal O'Connell takes MTPConnect on a virtual tour of the lab.